title: Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.
abstract: On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of methoxetamine as a new recreational trend is here provided. Those methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, are here discussed as well. It is concluded that the online availability of information on novel psychoactive drugs, such as methoxethanine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast-growing phenomenon.
authors.affiliation: School of Pharmacy, University of Hertfordshire, Hatfield, UK. o.corazza@herts.ac.uk
authors.forename: Ornella
authors.initials: O
authors.lastname: Corazza
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Schifano
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Simonato
authors.forename: Suzanne
authors.initials: S
authors.lastname: Fergus
authors.forename: Sulaf
authors.initials: S
authors.lastname: Assi
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Stair
authors.forename: John
authors.initials: J
authors.lastname: Corkery
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Trincas
authors.forename: Paolo
authors.initials: P
authors.lastname: Deluca
authors.forename: Zoe
authors.initials: Z
authors.lastname: Davey
authors.forename: Ursula
authors.initials: U
authors.lastname: Blaszko
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Demetrovics
authors.forename: Jacek
authors.initials: J
authors.lastname: Moskalewicz
authors.forename: Aurora
authors.initials: A
authors.lastname: Enea
authors.forename: Giuditta
authors.initials: G
authors.lastname: di Melchiorre
authors.forename: Barbara
authors.initials: B
authors.lastname: Mervo
authors.forename: Lucia
authors.initials: L
authors.lastname: di Furia
authors.forename: Magi
authors.initials: M
authors.lastname: Farre
authors.forename: Liv
authors.initials: L
authors.lastname: Flesland
authors.forename: Manuela
authors.initials: M
authors.lastname: Pasinetti
authors.forename: Cinzia
authors.initials: C
authors.lastname: Pezzolesi
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Pisarska
authors.forename: Harry
authors.initials: H
authors.lastname: Shapiro
authors.forename: Holger
authors.initials: H
authors.lastname: Siemann
authors.forename: Arvid
authors.initials: A
authors.lastname: Skutle
authors.forename: Aurora
authors.initials: A
authors.lastname: Enea
authors.forename: Giuditta
authors.initials: G
authors.lastname: di Melchiorre
authors.forename: Elias
authors.initials: E
authors.lastname: Sferrazza
authors.forename: Marta
authors.initials: M
authors.lastname: Torrens
authors.forename: Peer
authors.initials: P
authors.lastname: van der Kreeft
authors.forename: Daniela
authors.initials: D
authors.lastname: Zummo
authors.forename: Norbert
authors.initials: N
authors.lastname: Scherbaum
mesh_terms: D003512:Cyclohexanones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D003514:Cyclohexylamines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D015198:Designer Drugs / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D006213:Hallucinogens / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D007391:International Cooperation; D020407:Internet; D007649:Ketamine / Q000493:pharmacokinetics / Q000494:pharmacology; D011634:Public Health; D019966:Substance-Related Disorders / Q000453:epidemiology; D013997:Time Factors
chemical_list: D003512:Cyclohexanones; D003514:Cyclohexylamines; D015198:Designer Drugs; D006213:Hallucinogens; D013287:Illicit Drugs; D007649:Ketamine; C569113:2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone